MicroRNA Antagonism of the Picornaviral Life Cycle: Alternative Mechanisms of Interference
In addition to modulating the function and stability of cellular mRNAs, microRNAs can profoundly affect the life cycles of viruses bearing sequence complementary targets, a finding recently exploited to ameliorate toxicities of vaccines and oncolytic viruses. To elucidate the mechanisms underlying microRNA-mediated antiviral activity, we modified the 3′ untranslated region (3′UTR) of Coxsackievirus A21 to incorporate targets with varying degrees of homology to endogenous microRNAs. We show that microRNAs can interrupt the picornavirus life-cycle at multiple levels, including catalytic degradation of the viral RNA genome, suppression of cap-independent mRNA translation, and interference with genome encapsidation. In addition, we have examined the extent to which endogenous microRNAs can suppress viral replication in vivo and how viruses can overcome this inhibition by microRNA saturation in mouse cancer models.
Vyšlo v časopise:
MicroRNA Antagonism of the Picornaviral Life Cycle: Alternative Mechanisms of Interference. PLoS Pathog 6(3): e32767. doi:10.1371/journal.ppat.1000820
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000820
Souhrn
In addition to modulating the function and stability of cellular mRNAs, microRNAs can profoundly affect the life cycles of viruses bearing sequence complementary targets, a finding recently exploited to ameliorate toxicities of vaccines and oncolytic viruses. To elucidate the mechanisms underlying microRNA-mediated antiviral activity, we modified the 3′ untranslated region (3′UTR) of Coxsackievirus A21 to incorporate targets with varying degrees of homology to endogenous microRNAs. We show that microRNAs can interrupt the picornavirus life-cycle at multiple levels, including catalytic degradation of the viral RNA genome, suppression of cap-independent mRNA translation, and interference with genome encapsidation. In addition, we have examined the extent to which endogenous microRNAs can suppress viral replication in vivo and how viruses can overcome this inhibition by microRNA saturation in mouse cancer models.
Zdroje
1. LewisBP
BurgeCB
BartelDP
2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 15 20
2. Griffiths-JonesS
SainiHK
van DongenS
EnrightAJ
2008 miRBase: tools for microRNA genomics. Nucleic Acids Res 36 D154 158
3. HuangQ
GumireddyK
SchrierM
le SageC
NagelR
2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10 202 210
4. BartelDP
2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 281 297
5. BrownBD
GentnerB
CantoreA
ColleoniS
AmendolaM
2007 Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol
6. WesterhoutEM
OomsM
VinkM
DasAT
BerkhoutB
2005 HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33 796 804
7. GuS
JinL
ZhangF
SarnowP
KayMA
2009 Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16 144 150
8. PillaiRS
BhattacharyyaSN
ArtusCG
ZollerT
CougotN
2005 Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309 1573 1576
9. HumphreysDT
WestmanBJ
MartinDI
PreissT
2005 MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 102 16961 16966
10. BarnesD
KunitomiM
VignuzziM
SakselaK
AndinoR
2008 Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4 239 248
11. CawoodR
ChenHH
CarrollF
Bazan-PeregrinoM
van RooijenN
2009 Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog 5 e1000440 doi:10.1371/journal.ppat.1000440
12. YlosmakiE
HakkarainenT
HemminkiA
VisakorpiT
AndinoR
2008 Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J Virol 82 11009 11015
13. KellyEJ
HadacEM
GreinerS
RussellSJ
2008 Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14 1278 1283
14. JoplingCL
YiM
LancasterAM
LemonSM
SarnowP
2005 Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309 1577 1581
15. BrownBD
VenneriMA
ZingaleA
Sergi SergiL
NaldiniL
2006 Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12 585 591
16. GottweinE
CullenBR
2008 Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 375 387
17. SullivanCS
GrundhoffAT
TevethiaS
PipasJM
GanemD
2005 SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435 682 686
18. PedersenIM
ChengG
WielandS
VoliniaS
CroceCM
2007 Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449 919 922
19. KellyEJ
RussellSJ
2009 MicroRNAs and the regulation of vector tropism. Mol Ther 17 409 416
20. SchiffGM
SherwoodJR
2000 Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis 181 20 26
21. DekelB
YoeliR
ShulmanL
PadehS
PasswellJH
2002 Localized thigh swelling mimicking a neoplastic process: involvement of coxsackie virus type A21. Acta Paediatr 91 357 359
22. FilipowiczW
BhattacharyyaSN
SonenbergN
2008 Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 102 114
23. PetersenCP
BordeleauME
PelletierJ
SharpPA
2006 Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21 533 542
24. MathonnetG
FabianMR
SvitkinYV
ParsyanA
HuckL
2007 MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317 1764 1767
25. GentnerB
SchiraG
GiustacchiniA
AmendolaM
BrownBD
2009 Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6 63 66
26. TeterinaNL
ZhouWD
ChoMW
EhrenfeldE
1995 Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol 69 4245 4254
27. Van Der VeldenA
KaminskiA
JacksonRJ
BelshamGJ
1995 Defective point mutants of the encephalomyocarditis virus internal ribosome entry site can be complemented in trans. Virology 214 82 90
28. JiaXY
Van EdenM
BuschMG
EhrenfeldE
SummersDF
1998 trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol 72 7972 7977
29. EtchisonD
MilburnSC
EderyI
SonenbergN
HersheyJW
1982 Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257 14806 14810
30. RoseJK
TrachselH
LeongK
BaltimoreD
1978 Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A 75 2732 2736
31. WienMW
ChowM
HogleJM
1996 Poliovirus: new insights from an old paradigm. Structure 4 763 767
32. EbertMS
NeilsonJR
SharpPA
2007 MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4 721 726
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 3
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein Binds and Protects a Nuclear Noncoding RNA from Cellular RNA Decay Pathways
- Endocytosis of the Anthrax Toxin Is Mediated by Clathrin, Actin and Unconventional Adaptors
- Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells
- Inhibition of Macrophage Migration Inhibitory Factor Ameliorates Ocular -Induced Keratitis